Jiangsu Chia Tai Tianqing Pharmaceutical Co Ltd, Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd, Qingdao Chia Tai Haier Pharmaceutical Co Ltd, Jiangsu Chia Tai Qing Jiang Pharmaceutical Co Ltd, etc. Nanjing Chia Tai Tianqing Pharmaceutical Co Ltd
In what is being hailed as the biggest ever landmark buyout involving Chinese biopharma companies, Sino Biopharmaceutical is to acquire compatriot LaNova Medicines as it endeavors to rapidly progress
Akeso has garnered a regulatory nod for penpulimab from the US Food and Drug Administration, making the agent the second PD-1 checkpoint inhibitor originating from a Chinese drug maker in the US marke
One of the main topics of conversation at the beginning of 2025 is how pharma companies should build their pipelines and the rising role that China is playing. A widely-cited report from Stifel show
AstraZeneca ended last year as the world’s seventh largest pharma company by market cap – but as the leading group when it comes to starting clinical trials. Last year AstraZeneca kicked off 139 tri